Skip to main content

Animations

MJFF Publications

5251 - 5260 of 8673 Results
Title
Year
  • Year
  • 2022
  • 2020
  • 2021
  • 2024
  • 2021
  • 2018
  • 2018
  • 2019
  • 2023
  • 2018
  • Summary Details
    OPEN
    Title: The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cell.2022.05.008
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-020-04897-6
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28533
    Citation Count: 51
  • Summary Details
    RESTRICTED
    Title: Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplex
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2024.2340399
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202013257
    Citation Count: 129
  • Summary Details
    OPEN
    Title: PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity termination
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.201708053
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2019.06.014
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-239901
    Citation Count: 62
  • Summary Details
    RESTRICTED
    Title: Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-018-1892-1
    Citation Count: 58
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.